Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

leonardo drs - DRS

DRS

Close Chg Chg %
33.93 1.18 3.48%

Closed Market

35.11

+1.18 (3.48%)

Volume: 497.32K

Last Updated:

Nov 19, 2024, 4:00 PM EDT

Trade Now

Company Overview: leonardo drs - DRS

DRS Key Data

Open

$34.20

 Day Range

34.02 - 35.20

52 Week Range

17.97 - 37.99

 Market Cap

$1.47B

Shares Outstanding

145.00M

 Public Float

73.80M

Beta

N/A

 Rev. Per Employee

N/A

P/E Ratio

3.52

 EPS

N/A

Yield

N/A

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

681.50K

  

DRS Performance

1 Week
 
 0.62%
 
1 Month
 
 18.14%
 
3 Months
 
 19.39%
 
1 Year
 
 82.81%
 
5 Years
 
 574.55%
 

DRS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About leonardo drs - DRS

Leonardo DRS, Inc. engages in the provision of defense products and technologies. It develops and manufactures defense products for the U.S. military, intelligence agencies and allies around the world. Its broad technology portfolio focuses on advanced sensing, network computing, force protection, and electrical power and propulsion, as well as a range of key defense priorities. The company operates through two segments: Advanced Sensors & Computing, and Integrated Mission Systems. The Advanced Sensors & Computing segment has been aligned to push towards a more autonomous future. It consists of six business units, which include Airborne & Intelligence Systems, Daylight Solutions, DRS RADA Technologies, Electro-Optical & Infrared Systems, Land Electronics, and Naval Electronics. The Integrated Mission Systems segment consists of both a ground vehicle integrator and naval power and propulsion system provider. Leonardo DRS was founded by Leonard Newman and David E. Gross in 1969 and is headquartered in Arlington, VA.

DRS At a Glance

Leonardo DRS, Inc.
2345 Crystal Drive
Arlington, Virginia 22202
Phone 1-703-416-8000 Revenue 2.83B
Industry Aerospace & Defense Net Income 168.00M
Sector Electronic Technology 2023 Sales Growth 4.939%
Fiscal Year-end 12 / 2024 Employees 6,600
View SEC Filings

DRS Valuation

P/E Current 3.518
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 31.49
Price to Sales Ratio 1.872
Price to Book Ratio 2.263
Price to Cash Flow Ratio 25.808
Enterprise Value to EBITDA 15.93
Enterprise Value to Sales 1.883
Total Debt to Enterprise Value 0.093

DRS Efficiency

Revenue/Employee 428,181.818
Income Per Employee 25,454.545
Receivables Turnover 2.669
Total Asset Turnover 0.721

DRS Liquidity

Current Ratio 1.779
Quick Ratio 1.474
Cash Ratio 0.433

DRS Profitability

Gross Margin 22.151
Operating Margin 8.811
Pretax Margin 6.794
Net Margin 5.945
Return on Assets 4.285
Return on Equity 7.547
Return on Total Capital 5.953
Return on Invested Capital 6.337

DRS Capital Structure

Total Debt to Total Equity 21.376
Total Debt to Total Capital 17.612
Total Debt to Total Assets 12.305
Long-Term Debt to Equity 17.935
Long-Term Debt to Total Capital 14.777
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Leonardo Drs - DRS

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
2.78B 2.88B 2.69B 2.83B
Sales Growth
+2.36% +3.64% -6.46% +4.94%
Cost of Goods Sold (COGS) incl D&A
2.29B 2.34B 2.13B 2.20B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
53.00M 58.00M 65.00M 85.00M
Depreciation
44.00M 49.00M 55.00M 63.00M
Amortization of Intangibles
9.00M 9.00M 10.00M 22.00M
COGS Growth
+1.28% +2.09% -9.10% +3.38%
Gross Income
485.00M 538.00M 565.00M 626.00M
Gross Income Growth
+7.78% +10.93% +5.02% +10.80%
Gross Profit Margin
+17.46% +18.69% +20.98% +22.15%
2020 2021 2022 2023 5-year trend
SG&A Expense
283.00M 293.00M 314.00M 377.00M
Research & Development
- - - -
-
Other SG&A
283.00M 293.00M 314.00M 377.00M
SGA Growth
+2.17% +3.53% +7.17% +20.06%
Other Operating Expense
- 21.00M 9.00M (2.00M)
Unusual Expense
- - 46.00M 18.00M
-
EBIT after Unusual Expense
181.00M 236.00M 207.00M 231.00M
Non Operating Income/Expense
(5.00M) (1.00M) 352.00M (3.00M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
64.00M 35.00M 34.00M 36.00M
Interest Expense Growth
-1.54% -45.31% -2.86% +5.88%
Gross Interest Expense
64.00M 35.00M 34.00M 36.00M
Interest Capitalized
- - - -
-
Pretax Income
112.00M 200.00M 525.00M 192.00M
Pretax Income Growth
+17.89% +78.57% +162.50% -63.43%
Pretax Margin
+4.03% +6.95% +19.49% +6.79%
Income Tax
27.00M 46.00M 120.00M 24.00M
Income Tax - Current - Domestic
3.00M (1.00M) 117.00M 75.00M
Income Tax - Current - Foreign
- 2.00M 1.00M 1.00M
Income Tax - Deferred - Domestic
24.00M 48.00M (1.00M) (51.00M)
Income Tax - Deferred - Foreign
(2.00M) (2.00M) 4.00M (1.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
85.00M 154.00M 405.00M 168.00M
Minority Interest Expense
- - - -
-
Net Income
85.00M 154.00M 405.00M 168.00M
Net Income Growth
+13.33% +81.18% +162.99% -58.52%
Net Margin Growth
+3.06% +5.35% +15.04% +5.94%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
85.00M 154.00M 405.00M 168.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
85.00M 154.00M 405.00M 168.00M
EPS (Basic)
0.5675 1.06 1.8837 0.6437
EPS (Basic) Growth
+9.73% +86.78% +77.71% -65.83%
Basic Shares Outstanding
149.78M 145.00M 215.00M 261.00M
EPS (Diluted)
0.5675 1.06 1.8837 0.6364
EPS (Diluted) Growth
+9.73% +86.78% +77.71% -66.22%
Diluted Shares Outstanding
149.78M 145.00M 215.00M 264.00M
EBITDA
234.00M 294.00M 318.00M 334.00M
EBITDA Growth
+9.35% +25.64% +8.16% +5.03%
EBITDA Margin
+8.42% +10.21% +11.81% +11.82%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 34.375
Number of Ratings 9 Current Quarters Estimate 0.351
FY Report Date 12 / 2024 Current Year's Estimate 0.90
Last Quarter’s Earnings 0.24 Median PE on CY Estimate N/A
Year Ago Earnings 0.73 Next Fiscal Year Estimate 1.052
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 3 8 8
Mean Estimate 0.35 0.17 0.90 1.05
High Estimates 0.37 0.18 0.92 1.10
Low Estimate 0.34 0.17 0.85 1.04
Coefficient of Variance 2.83 3.33 2.41 1.90

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 4
OVERWEIGHT 1 1 1
HOLD 4 4 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Leonardo Drs - DRS

Date Name Shares Transaction Value
Jun 5, 2024 Mary E. Gallagher Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 George W. Casey Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 George W. Casey Director 20,310 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Eric C. Salzman Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Eric C. Salzman Director 16,739 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Frances Fragos Townsend Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Frances Fragos Townsend Director 20,310 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Kenneth J. Krieg Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Kenneth J. Krieg Director 20,310 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Louis Reginald Brothers Director 14,322 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Gail S. Baker Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Louis Reginald Brothers Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Gail S. Baker Director 20,310 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 David W. Carey Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 David W. Carey Director 20,310 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Mary E. Gallagher Director 20,310 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 9, 2024 Pamela J. Morrow SVP and Controller 7,551 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 9, 2024 William J. Lynn Chief Executive Officer; Director 95,260 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 9, 2024 Michael D. Dippold EVP and CFO 20,446 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 9, 2024 Sally A. Wallace EVP, Business Operations 13,011 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Leonardo Drs in the News